As a company that promotes and lives its core values of Husay, Malasakit and Bayanihan, leading pharmaceutical and healthcare firm Unilab Inc. (Unilab) has partnered with the Yellow Boat of Hope ...

Unilab Pharma Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 5.0 lakhs and has ...

As artificial intelligence (AI) starts to reshape industries and redefines the global job market, Unilab Education (UniEd) has partnered with Massachusetts Institute of Technology (MIT)-based ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand ...

She sees the most promising areas for cooperation are technology, pharmaceuticals and medical devices, agri-food, sustainability, logistics, infrastructure, and energy. “These are the areas that we ...

PhilHealth president Edwin Mercado recently met with leaders of the pharmaceutical industry to discuss the agency’s efforts to reduce out-of-pocket expenses for Filipinos. To date, PhilHealth ...

REUTERS/Arnd Wiegmann Swiss pharmaceutical giant Novartis says it is watching "very carefully" how the reciprocal tariff policy proposed by the United States would unfold in early April ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

In 2025, pharma companies must enable an instantaneous data-to-decision value chain that is AI-powered, cloud-based, and product-enabled. You need to ingest data rapidly, manage it, keep it ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

Drugmakers agree to participate in second round of price negotiations All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...